A cleansing agent for the female intimate area containing live lactic acid bacteria, and a method for manufacturing the same.

A cleansing agent with freeze-dried lactic acid bacteria and silicon dioxide maintains vaginal health by stabilizing the bacteria, addressing the challenge of delivering live bacteria daily without preservatives, ensuring effective vaginal pH maintenance.

JP2026178488APending Publication Date: 2026-11-09西森 健郎
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2025073805
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-04-27
Publication Date
2026-11-09

AI Technical Summary

Technical Problem

Existing cleansing agents struggle to stably retain live lactic acid bacteria, making it difficult for women to deliver these bacteria into the vagina daily without resistance, and often require preservatives that can kill the bacteria.

Method used

A cleansing agent is formulated with freeze-dried live lactic acid bacteria, mixed with a suitable surfactant and silicon dioxide to maintain a water activity of 0.2 or less, and packaged in individual pouches made of specific materials to ensure stability and usability.

Benefits of technology

The agent effectively and stably retains live lactic acid bacteria, allowing women to deliver them into the vagina daily without reluctance, thereby maintaining vaginal health and preventing infections.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

This invention provides a cleansing agent for the female intimate area that effectively and stably retains live lactic acid bacteria, allowing women to deliver live lactic acid bacteria into the vagina on a daily basis without any resistance, and also provides a method for manufacturing the same. [Solution] A cleansing agent for the female intimate area is obtained by mixing a surfactant and silicon dioxide, adding freeze-dried live Lactobacillus jensenii and freeze-dried live Lactobacillus rhamnosus, and further adding a humectant, base, texture enhancer, and anti-inflammatory agent. The obtained cleansing agent for the female intimate area is then individually packaged in a pouch made of PET, aluminum, LLDPE, CPP, or a multilayer structure of two or more layers containing these materials to produce a cleansing product for the female intimate area.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a cleansing agent for the intimate area of women.

Background Art

[0002] In the present application, the intimate area of women means the female external genitalia, that is, the mons pubis, labia majora, labia minora, clitoris, vaginal vestibule, and perineum.

[0003] A wide variety of bacteria inhabit the vaginal cavity, among which lactic acid bacteria are dominant. Since lactic acid bacteria produce lactic acid as a final product, the pH in a healthy vagina is maintained at a weakly acidic level of about 4.0. In an environment with a pH of about 4.0, harmful bacteria and fungi such as Candida cannot proliferate, so the inside of the vagina is maintained in a healthy state.

[0004] However, when the number of lactic acid bacteria in the vagina decreases due to accumulated fatigue, lack of sleep, reduced immunity caused by stress, use of alkaline soap, cleansing with detergents containing fragrances or preservatives, frequent sexual intercourse, age-related decrease in estrogen, etc., the pH in the vagina rises, the aforementioned harmful bacteria and fungi proliferate, and there is a risk of developing bacterial vaginosis, chlamydial cervicitis, trichomonal vaginitis, candidal vaginitis and the like.

[0005] To compensate for the decrease of lactic acid bacteria in the vagina and maintain the health of the vaginal environment, various agents containing lactic acid bacteria or products of lactic acid bacteria have been proposed. What is important in such attempts is to maintain the vaginal pH at about 4.0. For this purpose, it is desirable to have lactic acid bacteria colonize the vagina, and to achieve this, it is first essential to deliver viable lactic acid bacteria into the vagina.

[0006] Patent Document 1 proposes a lactic acid bacteria fermented liquid extract. However, since this is not lactic acid bacteria itself, its effects are thought to be temporary. Patent Document 2 proposes suppositories and vaginal capsules containing freeze-dried Lactobacillus rhamnosus. Patent Document 3 proposes inserting a solid, semi-solid, liquid, or film-forming formulation containing lactic acid bacteria into the vaginal cavity using a device. Patent Document 4 proposes administering freeze-dried lactic acid bacteria to patients by placing them in capsules, suppositories, or soluble gels. The formulations proposed in Patent Documents 2 to 4 are medicinal, and healthy women are likely to feel hesitant to use them routinely for preventative purposes.

[0007] While there are cleansers for women's intimate areas that contain sterilized lactic acid bacteria, there are no products on the market that stably contain live lactic acid bacteria. In liquid or gel form, the presence of water reduces the stability of live lactic acid bacteria, making long-term storage difficult. Furthermore, the addition of preservatives and additives is often necessary, and these ingredients may kill the lactic acid bacteria themselves. Moreover, even freeze-dried powdered lactic acid bacteria can be reactivated in environments with high water activity, ultimately leading to their death. Thus, providing a cleansing agent that effectively and stably retains live lactic acid bacteria is difficult. [Prior art documents] [Patent Documents]

[0008] [Patent Document 1] Japanese Patent Publication No. 2004-067599 [Patent Document 2] Special Publication 2018-520677 [Patent Document 3] Special Publication 2024-509846 [Patent Document 4] Special Publication 2023-527876 [Overview of the Initiative] [Problems that the invention aims to solve]

[0009] The problem that the present invention aims to solve is to provide a cleansing agent for the female delicate zone and a method for manufacturing the same, which effectively and stably retains live lactic acid bacteria, allowing women to deliver live lactic acid bacteria into the vagina on a daily basis without any resistance. [Means for solving the problem]

[0010] As a result of diligent research, the inventors of this invention have conceived of a method to deliver live lactic acid bacteria stably to users by freeze-drying live lactic acid bacteria, mixing them with a surfactant, and adding silicon dioxide to maintain a water activity of 0.2 or less in the resulting product. While Lactobacillus jensenii and Lactobacillus rhamnosus are preferred as lactic acid bacteria, other lactic acid bacteria such as live Lactobacillus crispatus, live Lactobacillus gasseri, live Lactobacillus iners, live Lactobacillus reuteri, live Lactobacillus fermentum, live Lactobacillus salivarius, live Lactobacillus plantarum, and live Lactobacillus casei can also be used. As a surfactant, one should be selected that does not adversely affect lactic acid bacteria. Suitable surfactants include amino acid-based surfactants, amphoteric surfactants, nonionic surfactants, or mixtures thereof, such as sodium cocoyl methyl taurate, sodium olefin (C14-16) sulfonate, sodium stearoyl glutamate, sodium palm fatty acid glutamate, stearoyl glutamate, sodium lauroyl glutamate, potassium myristoyl glutamate, sodium myristoyl glutamate, sodium cocoyl glutamate, potassium cocoyl glycinate, sodium lauroamphoacetate, cocamidopropyl betaine, sodium cocoyl isethionate, sodium cocoyl sarcosinate, sodium cocoamphoacetate, sodium cocoyl glycinate, cocamide MEA, lauryl glucoside, decyl glucoside, sodium polyoxyethylene lauryl ether sulfate, and polyoxyethylene alkyl ether sulfate.

[0011] To improve the stability and usability of the women's intimate area cleanser according to the present invention, it is desirable to further add a moisturizer, base, texture enhancer, and anti-inflammatory agent. Suitable moisturizers include trehalose, glycogen, α-glucan oligosaccharide, sodium hyaluronate, and hydrolyzed collagen. Suitable bases include corn starch and maltodextrin. Suitable texture enhancers include guar hydroxypropyltrimonium chloride. Suitable anti-inflammatory agents include allantoin.

[0012] Regarding the content of each component of the cleansing agent for the female intimate area according to the present invention, it is preferable that the content of freeze-dried live lactic acid bacteria be 0.5 to 6%, the content of surfactant be 40 to 80%, the content of silicon dioxide be 10 to 30%, and the total content of moisturizer, base, texture improver, and anti-inflammatory agent be 5 to 20%.

[0013] The present invention provides a cleansing agent for women's intimate areas that is substantially free of antimicrobial growth inhibitors such as preservatives, antioxidants, and bactericides.

[0014] Furthermore, in order to maintain the quality of the women's intimate area cleanser according to the present invention until immediately before use, it is appropriate to individually package the product in a pouch made of PET (polyethylene terephthalate), aluminum, LLDPE (linear low-density polyethylene), CPP (cast polypropylene), or a multilayer structure of two or more layers containing these materials, in a single-use amount of approximately 0.5g. By individually packaging the product in a pouch in this manner, the stability of the viable bacteria can be maintained.

[0015] The cleansing product for women's delicate areas according to the present invention is manufactured by mixing a surfactant and silicon dioxide with freeze-dried live lactic acid bacteria, adding ingredients consisting of a moisturizer, a base, a texture enhancer, and an anti-inflammatory agent, and individually packaging this mixture in single-use portions in pouches made of PET, aluminum, LLDPE, CPP, or a multilayer structure of two or more layers containing these materials.

[0016] The method of using the women's intimate area cleansing product according to the present invention is as follows: After getting out of the bathtub at the end of a bath, take one packet of the product onto your palm, add lukewarm water and lather, wash the intimate area by gently rolling the lather over it, leave it still for 1 to 2 minutes, and then rinse off the lather to complete the process.

[0017] The first invention relates to a cleansing agent for the female intimate area, which contains one or more live bacteria selected from among Lactobacillus jensenii, Lactobacillus rhamnosus, Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus iners, Lactobacillus reuteri, Lactobacillus fermentum, Lactobacillus salivarius, Lactobacillus plantarum, and Lactobacillus casei, and further contains a surfactant and silicon dioxide, and is characterized by having a water activity of 0.2 or less.

[0018] The second invention relates to a cleansing agent for the female intimate area, which is the same as the first invention and is characterized by being substantially free of bacterial growth inhibitors such as preservatives, antioxidants, and bactericides.

[0019] The third invention relates to a cleansing agent for the female intimate area, which is the same as the second invention, characterized in that the surfactant is an amino acid-based surfactant, an amphoteric surfactant, a nonionic surfactant, or a mixture thereof, such as sodium cocoyl methyl taurate, sodium olefin (C14-16) sulfonate, sodium stearoyl glutamate, sodium palm fatty acid glutamate, stearoyl glutamic acid, sodium lauroyl glutamate, potassium myristoyl glutamate, sodium myristoyl glutamate, sodium cocoyl glutamate, potassium cocoyl glycinate, sodium lauroamphoacetate, cocamidopropyl betaine, sodium cocoyl isethionate, sodium cocoyl sarcosinate, sodium cocoamphoacetate, sodium cocoyl glycinate, cocamide MEA, lauryl glucoside, decyl glucoside, sodium polyoxyethylene lauryl ether sulfate, or polyoxyethylene alkyl ether sulfate.

[0020] The fourth invention is a cleansing agent for the female intimate area according to the third invention, characterized in that it contains 0.5 to 3% freeze-dried live Lactobacillus jensenii, 0.5 to 3% freeze-dried live Lactobacillus rhamnosus, 40 to 80% surfactant, and 10 to 30% silicon dioxide, and further, the total content of moisturizers, bases, texture improvers, and anti-inflammatory agents is 5 to 20%.

[0021] The fifth invention is a cleansing agent for the female intimate area relating to the fourth invention, characterized in that the surfactant is sodium cocoyl methyl taurate, the moisturizer is trehalose, glycogen, α-glucan oligosaccharide, sodium hyaluronate, and hydrolyzed collagen, the base is corn starch and maltodextrin, the texture improver is guar hydroxypropyltrimonium chloride, and the anti-inflammatory agent is allantoin.

[0022] A sixth invention is the method for producing the feminine intimate zone cleansing product according to the fourth or fifth invention, characterized by mixing the lyophilized viable Lactobacillus jensenii and the lyophilized viable Lactobacillus rhamnosus into a mixture of the aforementioned surfactant and the aforementioned silicon dioxide, further adding a humectant, a base material, a sensory improver, and an anti-inflammatory agent, and individually packaging the resulting mixture in a pouch package composed of PET, aluminum, LLDPE, CPP, or a multilayer structure of two or more layers containing these materials. [Effects of the Invention]

[0023] According to the present invention, there is provided a cleansing agent for the feminine intimate zone that effectively and stably retains viable lactic acid bacteria, and allows women to deliver viable lactic acid bacteria into the vagina by themselves on a daily basis without reluctance, as well as a method for producing the same. [Modes for Carrying Out the Invention]

[0024] Next, embodiments of the present invention will be described, and it goes without saying that various changes and modifications are possible without departing from the technical scope of the present invention. [Examples]

[0025] Mix 1 weight unit of freeze-dried Lactobacillus jensenii cells with 1 weight unit of freeze-dried Lactobacillus rhamnosus cells. Mix 65.85 weight units of sodium cocoyl methyl taurate with 19.2 weight units of silicon dioxide. Mix 85.05 weight units of this mixture of sodium cocoyl methyl taurate and silicon dioxide with 1.531 weight units of the aforementioned mixture of freeze-dried Lactobacillus jensenii cells and freeze-dried Lactobacillus rhamnosus cells. To this mixture, 9.4 units by weight of corn starch, 2 units by weight of trehalose, 1.5 units by weight of guar hydroxypropyltrimonium chloride, 0.01 unit by weight of glycogen, 0.01 unit by weight of α-glucan oligosaccharide, 0.01 unit by weight of sodium hyaluronate, 0.01 unit by weight of hydrolyzed collagen, 0.01 unit by weight of allantoin, and 0.469 units by weight of maltodextrin are mixed. The resulting mixture is individually packaged in 0.5g portions in aluminum pouches consisting of four layers: PET12, AL7, PET12, and LLDPE, thereby completing the cleansing product for women's delicate areas according to the present invention. [Industrial applicability]

[0026] The female intimate area cleanser according to the present invention can help maintain vaginal health and prevent vaginal infections when used daily by healthy women during bathing.

Claims

1. It contains one or more live Lactobacillus jensenii, Lactobacillus rhamnosus, Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus iners, Lactobacillus reuteri, Lactobacillus fermentum, Lactobacillus salivarius, Lactobacillus plantarum, and Lactobacillus casei, Furthermore, it contains a surfactant and silicon dioxide. The water activity is 0.2 or less. A cleansing agent for women's intimate areas, characterized by the following features.

2. A cleansing agent for the female intimate area according to claim 1, It is virtually free of antimicrobial growth inhibitors such as preservatives, antioxidants, and disinfectants. A cleansing agent for women's intimate areas, characterized by the following features.

3. A cleansing agent for the female intimate area according to claim 2, The above-mentioned surfactants are amino acid-based, amphoteric, nonionic surfactants, or mixtures thereof, such as sodium cocoyl methyl taurate, sodium olefin (C14-16) sulfonate, sodium stearoyl glutamate, sodium palm fatty acid glutamate, stearoyl glutamate, sodium lauroyl glutamate, potassium myristoyl glutamate, sodium myristoyl glutamate, sodium cocoyl glutamate, potassium cocoyl glycinate, sodium lauroamphoacetate, cocamidopropyl betaine, sodium cocoyl isethionate, sodium cocoyl sarcosinate, sodium cocoamphoacetate, sodium cocoyl glycinate, cocamide MEA, lauryl glucoside, decyl glucoside, sodium polyoxyethylene lauryl ether sulfate, and polyoxyethylene alkyl ether sulfate. A cleansing agent for women's intimate areas, characterized by the following features.

4. A cleansing agent for the female intimate area according to claim 3, The freeze-dried Lactobacillus jensenii live bacteria content is 0.5 to 3%. The freeze-dried Lactobacillus rhamnosus live bacteria content is 0.5 to 3%. The surfactant content is 40 to 80%. The silicon dioxide content is 10 to 30%, Furthermore, the total content of moisturizers, bases, texture enhancers, and anti-inflammatory agents is between 5% and 20%. A cleansing agent for women's intimate areas, characterized by the following features.

5. A cleansing agent for the female intimate area according to claim 4, The surfactant mentioned above is sodium cocoyl methyl taurate. The above-mentioned moisturizers are trehalose, glycogen, α-glucan oligosaccharide, sodium hyaluronate, and hydrolyzed collagen. The above base ingredients are corn starch and maltodextrin. The above texture-improving agent is guar hydroxypropyltrimonium chloride, The anti-inflammatory agent mentioned above is allantoin. A cleansing agent for women's intimate areas, characterized by the following features.

6. A method for manufacturing a cleansing product for the female intimate area according to claim 4 or 5, The above surfactant and the above silicon dioxide are mixed together, and then freeze-dried live Lactobacillus jensenii and freeze-dried live Lactobacillus rhamnosus are added to the mixture. Furthermore, moisturizers, bases, texture improvers, and anti-inflammatory agents are added. The resulting mixture is individually packaged in pouches made of PET, aluminum, LLDPE, CPP, or a multilayer structure of two or more layers containing these materials. A method for manufacturing a cleansing product for women's intimate areas, characterized by the following.

Citation Information

Patent Citations

  • In-vagina detergent

    JP2004067599A

  • For example, Lactobacillus rhamnosus bacteria for the treatment of bacterial vaginitis

    JP2018520677A

  • Vaginal Microbiota Composition

    JP2023527876A

  • Vaginal Microbiota Related Methods, Compositions, and Devices

    JP2024509846A